ID   LRC4C_HUMAN             Reviewed;         640 AA.
AC   Q9HCJ2; A8K0T1; Q7L0N3;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JUN-2023, entry version 174.
DE   RecName: Full=Leucine-rich repeat-containing protein 4C;
DE   AltName: Full=Netrin-G1 ligand;
DE            Short=NGL-1;
DE   Flags: Precursor;
GN   Name=LRRC4C; Synonyms=KIAA1580, NGL1; ORFNames=UNQ292/PRO331;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH NTNG1, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14595443; DOI=10.1038/nn1148;
RA   Lin J.C., Ho W.-H., Gurney A.L., Rosenthal A.;
RT   "The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical
RT   axons.";
RL   Nat. Neurosci. 6:1270-1276(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 44-444 IN COMPLEX WITH NTNG1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=21946559; DOI=10.1038/emboj.2011.346;
RA   Seiradake E., Coles C.H., Perestenko P.V., Harlos K., McIlhinney R.A.,
RA   Aricescu A.R., Jones E.Y.;
RT   "Structural basis for cell surface patterning through NetrinG-NGL
RT   interactions.";
RL   EMBO J. 30:4479-4488(2011).
CC   -!- FUNCTION: May promote neurite outgrowth of developing thalamic neurons.
CC       {ECO:0000269|PubMed:14595443}.
CC   -!- SUBUNIT: Interacts with NTNG1 and WHRN. {ECO:0000269|PubMed:14595443,
CC       ECO:0000269|PubMed:21946559}.
CC   -!- INTERACTION:
CC       Q9HCJ2; Q6RW13-2: AGTRAP; NbExp=3; IntAct=EBI-3925442, EBI-11522760;
CC       Q9HCJ2; O95393: BMP10; NbExp=3; IntAct=EBI-3925442, EBI-3922513;
CC       Q9HCJ2; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-3925442, EBI-12244618;
CC       Q9HCJ2; Q8N6F1-2: CLDN19; NbExp=3; IntAct=EBI-3925442, EBI-12256978;
CC       Q9HCJ2; Q8NC01: CLEC1A; NbExp=3; IntAct=EBI-3925442, EBI-11996768;
CC       Q9HCJ2; Q6UXB4: CLEC4G; NbExp=3; IntAct=EBI-3925442, EBI-2114729;
CC       Q9HCJ2; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-3925442, EBI-11522780;
CC       Q9HCJ2; Q9UPQ8: DOLK; NbExp=4; IntAct=EBI-3925442, EBI-8645574;
CC       Q9HCJ2; Q8N682: DRAM1; NbExp=3; IntAct=EBI-3925442, EBI-10305400;
CC       Q9HCJ2; P54852: EMP3; NbExp=3; IntAct=EBI-3925442, EBI-3907816;
CC       Q9HCJ2; P29033: GJB2; NbExp=3; IntAct=EBI-3925442, EBI-3905204;
CC       Q9HCJ2; O95214: LEPROTL1; NbExp=3; IntAct=EBI-3925442, EBI-750776;
CC       Q9HCJ2; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-3925442, EBI-2820517;
CC       Q9HCJ2; P30301: MIP; NbExp=3; IntAct=EBI-3925442, EBI-8449636;
CC       Q9HCJ2; Q9Y2I2: NTNG1; NbExp=4; IntAct=EBI-3925442, EBI-7444396;
CC       Q9HCJ2; Q96CW9: NTNG2; NbExp=2; IntAct=EBI-3925442, EBI-750795;
CC       Q9HCJ2; Q9UHJ9-5: PGAP2; NbExp=3; IntAct=EBI-3925442, EBI-12092917;
CC       Q9HCJ2; Q04941: PLP2; NbExp=3; IntAct=EBI-3925442, EBI-608347;
CC       Q9HCJ2; A2A2V5: SERTM1; NbExp=3; IntAct=EBI-3925442, EBI-17284533;
CC       Q9HCJ2; B2RUZ4: SMIM1; NbExp=3; IntAct=EBI-3925442, EBI-12188413;
CC       Q9HCJ2; Q5SQN1: SNAP47; NbExp=3; IntAct=EBI-3925442, EBI-10244848;
CC       Q9HCJ2; Q13190: STX5; NbExp=3; IntAct=EBI-3925442, EBI-714206;
CC       Q9HCJ2; Q9GZX9: TWSG1; NbExp=3; IntAct=EBI-3925442, EBI-10304067;
CC       Q9HCJ2; Q6UX27-3: VSTM1; NbExp=3; IntAct=EBI-3925442, EBI-12190699;
CC       Q9HCJ2; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-3925442, EBI-751210;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:14595443, ECO:0000269|PubMed:21946559}; Single-pass
CC       type I membrane protein {ECO:0000269|PubMed:14595443,
CC       ECO:0000269|PubMed:21946559}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the cerebral cortex, including
CC       frontal, parietal and occipital lobes. Putamen, amygdala, hippocampus
CC       and medulla oblongata show moderate expression. Caudate nucleus and
CC       thalamus express small amounts, whereas other brain regions show very
CC       weak or no expression. {ECO:0000269|PubMed:14595443}.
CC   -!- DOMAIN: The LRR region is both necessary and sufficient for the
CC       interaction with NTNG1.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB046800; BAB13406.1; -; mRNA.
DR   EMBL; AY358293; AAQ88660.1; -; mRNA.
DR   EMBL; AK289646; BAF82335.1; -; mRNA.
DR   EMBL; CH471064; EAW68107.1; -; Genomic_DNA.
DR   EMBL; BC041374; AAH41374.3; -; mRNA.
DR   CCDS; CCDS31464.1; -.
DR   RefSeq; NP_001245348.1; NM_001258419.1.
DR   RefSeq; NP_065980.1; NM_020929.2.
DR   RefSeq; XP_011518540.1; XM_011520238.2.
DR   RefSeq; XP_011518541.1; XM_011520239.2.
DR   RefSeq; XP_011518542.1; XM_011520240.2.
DR   RefSeq; XP_011518543.1; XM_011520241.2.
DR   RefSeq; XP_011518544.1; XM_011520242.2.
DR   RefSeq; XP_011518545.1; XM_011520243.2.
DR   RefSeq; XP_011518546.1; XM_011520244.2.
DR   RefSeq; XP_016873559.1; XM_017018070.1.
DR   RefSeq; XP_016873560.1; XM_017018071.1.
DR   RefSeq; XP_016873561.1; XM_017018072.1.
DR   RefSeq; XP_016873562.1; XM_017018073.1.
DR   RefSeq; XP_016873563.1; XM_017018074.1.
DR   RefSeq; XP_016873564.1; XM_017018075.1.
DR   RefSeq; XP_016873565.1; XM_017018076.1.
DR   RefSeq; XP_016873566.1; XM_017018077.1.
DR   RefSeq; XP_016873567.1; XM_017018078.1.
DR   RefSeq; XP_016873568.1; XM_017018079.1.
DR   PDB; 3ZYJ; X-ray; 3.25 A; A/C=44-444.
DR   PDBsum; 3ZYJ; -.
DR   AlphaFoldDB; Q9HCJ2; -.
DR   SMR; Q9HCJ2; -.
DR   BioGRID; 121715; 59.
DR   IntAct; Q9HCJ2; 49.
DR   MINT; Q9HCJ2; -.
DR   STRING; 9606.ENSP00000278198; -.
DR   iPTMnet; Q9HCJ2; -.
DR   PhosphoSitePlus; Q9HCJ2; -.
DR   BioMuta; LRRC4C; -.
DR   DMDM; 57012973; -.
DR   jPOST; Q9HCJ2; -.
DR   MassIVE; Q9HCJ2; -.
DR   PaxDb; Q9HCJ2; -.
DR   PeptideAtlas; Q9HCJ2; -.
DR   ProteomicsDB; 81737; -.
DR   Antibodypedia; 26031; 230 antibodies from 26 providers.
DR   DNASU; 57689; -.
DR   Ensembl; ENST00000278198.2; ENSP00000278198.1; ENSG00000148948.8.
DR   Ensembl; ENST00000527150.5; ENSP00000436976.1; ENSG00000148948.8.
DR   Ensembl; ENST00000528697.6; ENSP00000437132.1; ENSG00000148948.8.
DR   Ensembl; ENST00000530763.5; ENSP00000434761.1; ENSG00000148948.8.
DR   Ensembl; ENST00000619527.4; ENSP00000480903.1; ENSG00000148948.8.
DR   GeneID; 57689; -.
DR   KEGG; hsa:57689; -.
DR   MANE-Select; ENST00000528697.6; ENSP00000437132.1; NM_001258419.2; NP_001245348.1.
DR   UCSC; uc031pzt.2; human.
DR   AGR; HGNC:29317; -.
DR   CTD; 57689; -.
DR   DisGeNET; 57689; -.
DR   GeneCards; LRRC4C; -.
DR   HGNC; HGNC:29317; LRRC4C.
DR   HPA; ENSG00000148948; Tissue enhanced (brain, retina).
DR   MIM; 608817; gene.
DR   neXtProt; NX_Q9HCJ2; -.
DR   OpenTargets; ENSG00000148948; -.
DR   PharmGKB; PA142671534; -.
DR   VEuPathDB; HostDB:ENSG00000148948; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000157405; -.
DR   HOGENOM; CLU_000288_18_24_1; -.
DR   InParanoid; Q9HCJ2; -.
DR   OMA; TYKTAYN; -.
DR   OrthoDB; 4239630at2759; -.
DR   PhylomeDB; Q9HCJ2; -.
DR   TreeFam; TF324303; -.
DR   PathwayCommons; Q9HCJ2; -.
DR   SignaLink; Q9HCJ2; -.
DR   SIGNOR; Q9HCJ2; -.
DR   BioGRID-ORCS; 57689; 11 hits in 1143 CRISPR screens.
DR   ChiTaRS; LRRC4C; human.
DR   GenomeRNAi; 57689; -.
DR   Pharos; Q9HCJ2; Tbio.
DR   PRO; PR:Q9HCJ2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9HCJ2; protein.
DR   Bgee; ENSG00000148948; Expressed in middle temporal gyrus and 153 other tissues.
DR   ExpressionAtlas; Q9HCJ2; baseline and differential.
DR   Genevisible; Q9HCJ2; HS.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; IEA:Ensembl.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:SynGO-UCL.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IGI:SynGO-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0050770; P:regulation of axonogenesis; IDA:UniProtKB.
DR   GO; GO:0099560; P:synaptic membrane adhesion; IGI:SynGO-UCL.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR026906; LRR_5.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   PANTHER; PTHR24369; ANTIGEN BSP, PUTATIVE-RELATED; 1.
DR   PANTHER; PTHR24369:SF8; LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13306; LRR_5; 1.
DR   Pfam; PF13855; LRR_8; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00406; IGv; 1.
DR   SMART; SM00369; LRR_TYP; 8.
DR   SMART; SM00013; LRRNT; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51450; LRR; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Immunoglobulin domain;
KW   Leucine-rich repeat; Membrane; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Repeat; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..44
FT                   /evidence="ECO:0000255"
FT   CHAIN           45..640
FT                   /note="Leucine-rich repeat-containing protein 4C"
FT                   /id="PRO_0000015108"
FT   TRANSMEM        528..548
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          45..76
FT                   /note="LRRNT"
FT   REPEAT          77..98
FT                   /note="LRR 1"
FT   REPEAT          101..122
FT                   /note="LRR 2"
FT   REPEAT          125..146
FT                   /note="LRR 3"
FT   REPEAT          149..170
FT                   /note="LRR 4"
FT   REPEAT          173..195
FT                   /note="LRR 5"
FT   REPEAT          198..219
FT                   /note="LRR 6"
FT   REPEAT          220..241
FT                   /note="LRR 7"
FT   REPEAT          244..265
FT                   /note="LRR 8"
FT   REPEAT          268..289
FT                   /note="LRR 9"
FT   DOMAIN          301..353
FT                   /note="LRRCT"
FT   DOMAIN          354..442
FT                   /note="Ig-like C2-type"
FT   REGION          463..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         631
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C031"
FT   DISULFID        375..426
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   STRAND          49..53
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            93..96
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   HELIX           117..120
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            141..143
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            165..170
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          176..178
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            190..195
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            236..241
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          247..249
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            284..287
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          295..297
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   HELIX           310..317
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          329..333
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   TURN            334..338
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          363..366
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          376..379
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          382..387
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          393..398
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          401..405
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          411..415
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          422..429
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
FT   STRAND          434..444
FT                   /evidence="ECO:0007829|PDB:3ZYJ"
SQ   SEQUENCE   640 AA;  71950 MW;  6058974872636838 CRC64;
     MLNKMTLHPQ QIMIGPRFNR ALFDPLLVVL LALQLLVVAG LVRAQTCPSV CSCSNQFSKV
     ICVRKNLREV PDGISTNTRL LNLHENQIQI IKVNSFKHLR HLEILQLSRN HIRTIEIGAF
     NGLANLNTLE LFDNRLTTIP NGAFVYLSKL KELWLRNNPI ESIPSYAFNR IPSLRRLDLG
     ELKRLSYISE GAFEGLSNLR YLNLAMCNLR EIPNLTPLIK LDELDLSGNH LSAIRPGSFQ
     GLMHLQKLWM IQSQIQVIER NAFDNLQSLV EINLAHNNLT LLPHDLFTPL HHLERIHLHH
     NPWNCNCDIL WLSWWIKDMA PSNTACCARC NTPPNLKGRY IGELDQNYFT CYAPVIVEPP
     ADLNVTEGMA AELKCRASTS LTSVSWITPN GTVMTHGAYK VRIAVLSDGT LNFTNVTVQD
     TGMYTCMVSN SVGNTTASAT LNVTAATTTP FSYFSTVTVE TMEPSQDEAR TTDNNVGPTP
     VVDWETTNVT TSLTPQSTRS TEKTFTIPVT DINSGIPGID EVMKTTKIII GCFVAITLMA
     AVMLVIFYKM RKQHHRQNHH APTRTVEIIN VDDEITGDTP MESHLPMPAI EHEHLNHYNS
     YKSPFNHTTT VNTINSIHSS VHEPLLIRMN SKDNVQETQI
//
